For Immediate Release

Lacie Randall
Chief Creative Officer

Local Biopharma Company Supports Local Music Scene

Nashville, TN— November 29, 2016 — Leave it to an eclectic town like Nashville to bring together Grammy-award-winning musicians, a famous boy band member, an entertainment networking group featured in Forbes, and a 29-year-old Harvard entrepreneur who founded his own biotech company to celebrate the holidays. That’s exactly what’s happening tonight at 8:00pm at The Basement East, as the annual Young Entertainment Professionals (YEP) “Pause for the Claus” event takes place to give young musicians and music industry professionals alike an opportunity to mix, mingle, and jingle.
SHEPHERD Therapeutics patient-founder David Hysong had this to say about sponsoring such an event, “We chose to plant roots in Nashville because we knew it was a community of friends and a place to find people willing to help one another. Nashville has already proven a wonderful home both for me and for SHEPHERD, so we were grateful for the opportunity to help and support Nashville’s talented young artists through our involvement with YEP.”

Known as Music City, Nashville has always been known as the home of country music, but has in recent years, beckoned many other genres of artists and musicians, including one of the members of N*SYNC, Chris Kirkpatrick. Kirkpatrick is just one of the many artists performing tonight in an effort to bring together the community of talent in one beloved platform.

“We’re very excited to have SHEPHERD on board as a sponsor for one of our largest networking events of the year. It has always been important to our members we partner with organizations that not only assist financially, but also serve as mentors and take an interest in what we are doing to help progress the state of the music industry. David and the team at SHEPHERD have been an excellent example of that,” explained incoming YEP Executive Director, Amelia Varni.

About SHEPHERD Therapeutics
The mission of SHEPHERD Therapeutics is to cure rare cancers. Founded by a rare cancer patient, SHEPHERD is a life sciences company relentlessly focused on using deep disease understanding, development expertise, and unwavering commitment to save people dying of neglected rare cancers. SHEPHERD is changing the traditional economics and timeline of drug development, delivering better treatments faster for patients who previously had none. To join the mission or learn more, visit